# Anna Kostera-Pruszczyk, MD, PhD – FDA Inspection, Jul 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/anna-kostera-pruszczyk-md-phd/990897ab-490f-4f4e-a29e-b9aac799cdc4
Source feed: FDA_Inspections

> FDA inspection 1059483 of Anna Kostera-Pruszczyk, MD, PhD, July 13, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059483
- Company Name: Anna Kostera-Pruszczyk, MD, PhD
- Inspection Date: 2018-07-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/anna-kostera-pruszczyk-md-phd/7d22b78e-8f00-4c45-97aa-609d0330e965

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c